The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

por Karpova, D, Dauber, K, Spohn, G, Chudziak, D, Wiercinska, E, Schulz, M, Pettit, A R, Levesque, J P, Romagnoli, B, Patel, K, Chevalier, E, Dembowsky, K, Bonig, H
Publicado 2013